Corrigendum to “Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands” [The Lancet Regional Health—Europe, Volume 42, July 2024, 100927] (The Lancet Regional Health - Europe (2024) 42, (S2666776224000942), (10.1016/j.lanepe.2024.100927))

Jakob L. Schroevers*, Marieke P. Hoevenaar-Blom, Wim B. Busschers, Monika Hollander, Willem A. Van Gool, Edo Richard, Jan Willem Van Dalen, Eric P. Moll van Charante

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

1 Downloads (Pure)

Abstract

The authors have identified an error in the introduction of the main text. The correct statement should read: “Hypertension is an important risk factor for all-cause dementia, including Alzheimer's disease (AD). It affects over 70% of adults aged 60 and older,” rather than “Hypertension is an important risk factor for all-cause dementia, including Alzheimer's disease (AD), which is the cause of dementia in over 70% of adults aged 60 and older.” This correction pertains solely to the background information of this paper and does not impact the study's results or interpretations in any way. We apologize for any confusion this may have caused and are available to address any questions or comments.

Original languageEnglish
Article number101132
Number of pages1
JournalThe Lancet Regional Health - Europe
Volume47
DOIs
Publication statusPublished - Dec 2024

Fingerprint

Dive into the research topics of 'Corrigendum to “Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the Netherlands” [The Lancet Regional Health—Europe, Volume 42, July 2024, 100927] (The Lancet Regional Health - Europe (2024) 42, (S2666776224000942), (10.1016/j.lanepe.2024.100927))'. Together they form a unique fingerprint.

Cite this